ESSA Pharma Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q3 2019 to Q3 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
ESSA Pharma Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q3 2019 to Q3 2023.
- ESSA Pharma Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending September 30, 2023 was $43.7M, a 16% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)